{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T15:25:27Z","timestamp":1760887527274},"reference-count":16,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2004,8,16]],"date-time":"2004-08-16T00:00:00Z","timestamp":1092614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2004,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Aim<\/jats:bold> :\u2002To compare the safety and efficacy of pantoprazole and ranitidine in maintaining erosive oesophagitis healing.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> :\u2002Gastro\u2010oesophageal reflux disease patients (349) with endoscopically documented healed erosive oesophagitis (grade 0 or 1) were randomly assigned to receive pantoprazole (10, 20 or 40\u2003mg\/q.d.s.) or ranitidine (150\u2003mg\/b.d.). Erosive oesophagitis status was assessed endoscopically at months 1, 3, 6 and 12 or when relapse symptoms appeared (relapse\u2003=\u2003reappearance of erosive oesophagitis grade 2 within 12\u2003months). Symptom\u2010free days were also assessed.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> :\u2002Pantoprazole 20\u2010 and 40\u2010mg were significantly more effective than ranitidine in maintaining healing regardless of initial erosive oesophagitis grade. Response was dose\u2010related. After 12\u2003months 78, 55, 46 and 21% of patients remained healed (40\u2010, 20\u2010, 10\u2010mg pantoprazole and ranitidine). Pantoprazole 40\u2010mg produced significantly more symptom\u2010free days (83%) than ranitidine (58%). Heartburn\u2010free days\/nights were significantly higher with pantoprazole 40\u2010mg (92 and 93%) than ranitidine (73 and 77%). The most frequent reason for discontinuation, unsatisfactory efficacy, occurred most often with ranitidine (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001).<\/jats:p><jats:p><jats:bold>Conclusion<\/jats:bold> :\u2002Once\u2010daily pantoprazole therapy prevented relapse of healed erosive oesophagitis more effectively than ranitidine and with fewer heartburn days. Response to pantoprazole was dose\u2010related. Pantoprazole 40\u2010mg was the most effective regimen and consistent in maintaining erosive oesophagitis healing with a good safety and tolerability profile.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2004.02121.x","type":"journal-article","created":{"date-parts":[[2004,8,31]],"date-time":"2004-08-31T10:38:16Z","timestamp":1093948696000},"page":"567-575","source":"Crossref","is-referenced-by-count":21,"title":["Prevention of erosive oesophagitis relapse with pantoprazole"],"prefix":"10.1111","volume":"20","author":[{"given":"J. E.","family":"Richter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Fraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. M.","family":"Sabesin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Bochenek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"The Pantoprazole US GERD Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,8,16]]},"reference":[{"key":"e_1_2_17_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00882.x"},{"key":"e_1_2_17_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00185.x"},{"key":"e_1_2_17_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(88)90162-X"},{"key":"e_1_2_17_5_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528809093923"},{"key":"e_1_2_17_6_2","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1001\/archinte.1987.00370100031006","article-title":"Medical therapy for chronic reflux esophagitis. Long\u2010term follow\u2010up","volume":"147","author":"Lieberman DA.","year":"1987","journal-title":"Arch Intern Med"},{"key":"e_1_2_17_7_2","doi-asserted-by":"publisher","DOI":"10.1159\/000200917"},{"key":"e_1_2_17_8_2","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-199714060-00002"},{"key":"e_1_2_17_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1993.tb00582.x"},{"key":"e_1_2_17_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.36593"},{"key":"e_1_2_17_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000201275"},{"volume-title":"Clinical Efficacy and Tolerability of Pantoprazole 40\u2003mg vs. Pantoprazole 80\u2003mg in Patients with GERD","author":"Fischer R.","key":"e_1_2_17_12_2"},{"volume-title":"Clinical Efficacy of Pantoprazole vs. Omeprazole in Reflux Esophagitis","author":"Fischer R.","key":"e_1_2_17_13_2"},{"volume-title":"Physician's Desk Reference (Entry for Axid, Lilly)","year":"1998","author":"Medical Economics 1998","key":"e_1_2_17_14_2"},{"key":"e_1_2_17_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00651.x"},{"key":"e_1_2_17_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200012040-00010"},{"key":"e_1_2_17_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.03254.x"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02121.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02121.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2004.02121.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T17:13:11Z","timestamp":1697217191000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2004.02121.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,16]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["10.1111\/j.1365-2036.2004.02121.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2004.02121.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"type":"print","value":"0269-2813"},{"type":"electronic","value":"1365-2036"}],"subject":[],"published":{"date-parts":[[2004,8,16]]}}}